                               NIH Public Access
                               Author Manuscript
                               Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                           Published final edited form 
NIH-PA Author Manuscript




                            Chem Res Toxicol. 2013 January 18; 26(1): 156–168. doi:10.1021/tx300437x.



                           Synthesis Characterization DNA Minor Groove Binding
                           Alkylating Agents
                           Prema Iyer†, Ajay Srinivasan†, Sreelekha K. Singh†, Gerard P. Mascara†, Sevara Zayitova†,
                           Brian Sidone†, Elise Fouquerel§, David Svilar§,¥, Robert W. Sobol§,¥,#, Michael S. Bobola≠,
                           John R. Silber≠, Barry Gold†,*
                           †Department Pharmaceutical Sciences, University Pittsburgh, Pittsburgh, PA 15261

                           §University     Pittsburgh Cancer Institute, University Pittsburgh, Pittsburgh PA 15232
                           ¥Department        Pharmacology & Chemical Biology, University Pittsburgh, Pittsburgh, PA 15261
                           #Department        Human Genetics, University Pittsburgh 15213
                           ≠Department        Neurological Surgery, University Washington, Seattle, WA 98105
NIH-PA Author Manuscript




                           Abstract
                                 Derivatives methyl 3-(1-methyl-5-(1-methyl-5-(propylcarbamoyl)-1H-pyrrol-3-
                                 ylcarbamoyl)-1H-pyrrol-3-ylamino)-3-oxopropane-1-sulfonate (1), peptide-based DNA minor
                                 groove binding methylating agent, synthesized characterized. cases N-terminus
                                 appended O-methyl sulfonate ester C-terminus group varied non-
                                 polar polar sidechains. addition, number pyrrole rings varied 2 (dipeptide)
                                 3 (tripeptide). ability different analogues efficiently generate N3-methyladenine
                                 demonstrated selectivity minor groove (N3-methyladenine) vs. major groove
                                 (N7-methylguanine) methylation. Induced circular dichroism studies used measure                                  DNA equilibrium binding properties stable sulfone analogues; tripeptide binds                                  affinity > 10-fold higher dipeptide. toxicities compounds evaluated
                                 alkA/tag glycosylase mutant E. coli human WT glioma cells cells expressing
                                 expressing N-methylpurine-DNA glycosylase, excises N3-methyladenine                                  DNA. results equilibrium binding correlates levels N3-methyladenine
                                 produced cellular toxicity. toxicity 1 inversely related expression MPG                                  bacterial mammalian cell lines. enhanced toxicity parallels reduced activation
NIH-PA Author Manuscript




                                 PARP diminished rate formation aldehyde reactive sites observed MPG
                                 knockdown cells. proposed unrepaired N3-methyladenine toxic ability                                  directly block DNA polymerization.

                                              DNA damaging agents, affect DNA metabolism, continue extensively used                                               treatment cancer.1 interference DNA metabolism causes cell death                                               apoptosis necrosis, cells survive error free repair error prone bypass
                                              lesion. gives rise increased mutations associated higher cancer risk
                                              DNA damaging drugs listed International Agency Cancer
                                              Research human carcinogens.2 fact, significant incidence secondary cancers


                           *
                           Corresponding Author: Barry Gold; Telephone, 1-412-383-9593; goldbi@pitt.edu.
                           RWS scientific consultant Trevigen,  remaining authors state conflict 
                           Supporting Information
                           Synthetic details, NMR, MS spectra, HPLC traces, stability study details. material available free charge Internet                            http://pubs.acs.org.
                            Iyer et al.                                                                                               Page 2


                                           directly attributable treatment patients antineoplastic agents                                            primary cancer.3–6 DNA remains chemotherapeutic target cancers,                                            important minimize mutagenic effects. addition, new agents mechanisms NIH-PA Author Manuscript




                                           action overlap existing therapies, including react DNA,                                            potential overcome tumor resistance drugs.7–12

                                           previously developed alkylating agents related netropsin equilibrium bind                                             efficiently react  atoms line floor minor groove DNA T rich
                                           sequences, specifically N3-position adenine.13–17 O-methyl sulfonate ester                                            appended N-terminus N-methylpyrrolecarboxamide-based dipeptide combine
                                           alkylating activity DNA equilibrium binding (Figure 1, compound 1).13 C-
                                           terminus dipeptide capped n-propyl group,  making molecules
                                           neutral, unlike natural product minor groove binders, cationic. result                                            DNA equilibrium binder relatively weak affinity DNA.18 Despite weak affinity
                                           absence stabilizing electrostatic interactions, molecule efficiently                                            selectively reacts vitro cells yield N3-methyladenine (3-mA).13–18
                                           Compound 1 quite cytotoxic compared non-equilibrium binding alkylating agents,
                                           e.g., methyl methanesulfonate (MMS), relatively non-mutagenic.19–22 vitro data
                                           indicated toxicity results 3-mA lesion efficiently blocking DNA replication
                                           causing cell death.23–26 fact, weak mutagenicity 1 attributable                                            intermediate formation abasic sites base excision repair (BER) 3-mA.27
NIH-PA Author Manuscript




                                           synthesis characterization derivatives dipeptide 1                                            different C-termini additional peptide subunit analyze changes
                                           affect DNA methylation, affinity binding toxicity. explore mechanism                                            toxicity compounds generate 3-mA, performed studies using cells                                            WT human methylpurine DNA glycosylase (MPG), cells express MPG
                                           (MPG+) cells MPG knocked (MPG-). time course                                            formation abasic sites strand breaks 5-p-dR termini, PARP activation, PARP
                                           inactivation, caspase-3 -7 activation monitored. addition, microfluidic-
                                           assisted replication tract analysis used demonstrate 3-mA directly, indirectly,
                                           causes replication fork arrest cells. results provide new insights role                                            different BER intermediates repair processes cytotoxicity.

                               EXPERIMENTAL PROCEDURES
                               Materials reagents
                                           E. coli AB1157 (WT) E. coli GC4803 (AlkA/tag) obtained T. O’Connor (City
                                           Hope National Medical Center, Duarte, CA) L. Samson (Massachusetts Institute NIH-PA Author Manuscript




                                           Technology, Cambridge, MA). Human glioblastoma (T98G) cells obtained                                            American Type Culture Collection (Manassas, VA). CellTiter 96 AQueous Solution
                                           Reagent obtained Promega Corp (Madison, WI). T98G cells expressing
                                           human MPG developed essentially described previously plasmid
                                           transfection.28,29 Briefly, 1.5 × 105 cells seeded 60 mm dishes incubated                                            24–30 h 5  CO2 37 °C. human MPG expression plasmid (pCMV-MPG-IRES-
                                           Neo) transfected using FuGene 6 Transfection Reagent (Roche; Indianapolis, 
                                           according manufacturer’s instructions. Stable cell lines selected G418 2
                                           wk expression human MPG protein (nuclear extract) validated immunoblot
                                           analysis activity analysis, described30,31 MPG- cells developed                                            shRNA-mediated gene knockdown using lentivirus expressing MPG-specific shRNA.32                                            shRNA vectors used stable knockdown cell line development obtained glycerol
                                           stocks Sigma-Aldrich UPCI Lentiviral core facility (http://
                                           www.upci.upmc.edu/vcf/lenti.cfm). Lentiviral particles generated  collaboration

                                            Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                             Page 3


                                          UPCI Lentiviral facility) transfection 4 plasmids  shuttle vector plus
                                          packaging plasmids: pMD2.g(VSVG), pVSV-REV PMDLg/pRRE] 293-FT
                                          cells using FuGene 6 Transfection Reagent (Roche, Indianapolis, , described
NIH-PA Author Manuscript




                                          previously.28 Lentiviral transduction performed described earlier.28 Briefly, 6.0 ×
                                          104 cells seeded 6 plate 24 h transduction. Cells transduced                                           18 h 32 °C cultured 72 h 37 °C. Cells selected culturing                                           growth media 1.0 μg/mL puromycin, previously described.32

                                          DNA Damage Quantification kit (abasic site counting) purchased Dojindo
                                          Molecular Technologies (Rockville, MD). HT Colorimetric PARP Apoptosis Assay Kit                                           purchased Trevigen (Gaithersburg, MD). Pierce Cleaved PARP Colorimetric cell
                                          ELISA kit purchased Thermo Scientific (Rockford, . DNAzol reagent, cell
                                          culture components, Enzcheck® Caspase-3 Assay kit Alexa Fluor 488 annexin V/Dead
                                          Cell Apoptosis Kit purchased Invitrogen (Carlsbad, CA). Chemicals solvents
                                          purchased Sigma Aldrich Chemicals (St. Louis, MO). 10 Pd-C purchased
                                          Strem chemicals. Molecular biology grade buffers, plastic- glass-ware
                                          obtained Fisher Scientific (Pittsburgh, PA).

                               Synthesis DNA methylating agent 7
                                           Scheme 1 Supporting Information synthesis characterization                                           compounds). 1H NMR spectra collected Bruker instrument operating 400
NIH-PA Author Manuscript




                                          MHz data reported ppm.

                                          2,2,2-Trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)ethanone   prepared                                           previously described.33

                                          1-Methyl-4-nitro-N-propyl-1H-pyrrole-2-carboxamide (b) solution (3.47
                                          g, 12.78 mmol) 96 mL EtOAc added propylamine (31.95 mmol, 2.6 mL) drop
                                          wise 0 °C. reaction mixture stirred additional 1 h solvent
                                          evaporated b 98  yield. 1H NMR (CDCl3): δ 0.98 (t, 3H, J = 7.3), 1.57–1.66 (m,
                                          2H), 3.33–3.38 (m, 2H), 3.99 (s, 3H), 5.97 (s, br, 1H), 7.04 (d, 1H, J = 1.83), 7.55 (d, 1H, J
                                          = 1.83).

                                          4-Amino-1-methyl-N-propyl-1H-pyrrole-2-carboxamide (c) solution b (1g,
                                          4.73 mmol) EtOH (300 mL) added 10  Pd/C catalyst (300 mg) reaction
                                          shaken Parr apparatus 50 psi disappearance starting material (based TLC).
                                          reaction mixture filtered celite pad solvents evaporated dryness                                           quantitative yields c. 1H NMR (DMSO-d6) δ 0.84 (t, 3H, J = 7.42), 1.42–1.48 (m,
NIH-PA Author Manuscript




                                          2H), 3.05–3.09 (m, 2H), 3.66 (s, 3H), 6.16 (d, 1H, J = 1.95), 6.17 (d, 1H, J = 1.95), 7.70 (t,
                                          1H, J = 5.47).

                                          4-((t-Butoxycarbonyl)amino)-1-methyl-1H-pyrrole-2-carboxylic acid (d)                                           prepared previously reported.33

                                          t-Butyl(1-methyl-5-((1-methyl-5-(propylcarbamoyl)-1H-pyrrol-3-
                                          yl)carbamoyl)-1H-pyrrol-3-yl)carbamate (e) solution d (538 mg, 2.24 mmol)
                                          HOBT (454 mg, 3.36 mmol) anhydrous CH2Cl2 (30 mL) added Et3N (1.25 mL,
                                          8.96 mmol) EDC (859 mg, 4.48 mmol). reaction mixture stirred room
                                          temperature 1 h N2. 1 h, reaction mixture cooled amine c (609
                                          mg, 3.36 mmol) added CH2Cl2 (20 mL) containing Et3N (500 μL). reaction
                                          mixture stirred N2 18 h diluted CH2Cl2 washed H2O.
                                          aqueous layer extracted CH2Cl2, dried Na2SO4 solvent


                                            Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                              Page 4


                                         evaporated. residue purified silica gel column chromatography obtain e                                          86  yield. 1H NMR (DMSO-d6) δ 0.86 (t, 3H, J = 7.42), 1.45 (s, 9H), 1.46–1.52 (m, 2H),
                                         3.09–3.14 (m, 2H), 3.78 (s, 3H), 3.79 (s, 3H), 6.81 (s, br, 1H), 6.84 (d, 1H, J = 1.56), 6.88 (s,
NIH-PA Author Manuscript




                                         br, 1H), 7.15 (d, 1H, J = 1.95), 7.98 (t, 1H, J = 5.46), 9.09 (s, 1H), 9.80 (s, 1H).

                                         4-Amino-1-methyl-N-(1-methyl-5-(propylcarbamoyl)-1H-pyrrol-3-yl)-1H-pyrrole-
                                         2-carboxamide (f) solution e (671 mg, 1.66 mmol) anhydrous CH2Cl2 (8 mL)
                                         added 50  TFA:CH2Cl2 (v/v, 24 mL) 0 °C final concentration TFA
                                         approximately 40 . reaction mixture stirred 0 °C complete
                                         disappearance starting material (based TLC). solvent evaporated dryness                                          f quantitative yield. 1 H NMR (DMSO-d6) δ 0.86 (t, 3H, J = 7.42), 1.44–1.539 m,
                                         2H), 3.09–3.15 (m, 2H), 3.80 (s, 3H), 3.89 (s, 3H), 6.84 (d, 1H, J = 1.95), 6.94 (d, 1H, J =
                                         1.95), 7.11 (d, 1H, J = 1.95), 7.18 (d, 1H, J = 1.95), 8.01 (t, 1H, J = 5.46), 9.75 (s, 1H), 9.98
                                         (s, 1H).

                                         t-Butyl 1-methyl-4-nitro-1H-pyrrole-2-carboxylate (g) prepared previously
                                         described.34

                                         t-Butyl 4-acrylamido-1-methyl-1H-pyrrole-2-carboxylate (h) solution g
                                         (1.4 g, 6.19 mmol) MeOH (350 mL) added 10  Pd/C catalyst (1 g) reaction
                                         mixture shaken Parr apparatus 55 psi complete disappearance starting
NIH-PA Author Manuscript




                                         material  TLC). reaction mixture filtered celite pad solvents
                                         evaporated dryness afford amine quantitative yield (1.06 g, 5.40 mmol),                                          dissolved anhydrous THF (70 mL) DIEA (2.8 mL, 16.20 mmol). reaction
                                         mixture cooled −78 °C acryloyl chloride (658 μL, 8.10 mmol) added
                                         dropwise. reaction mixture maintained −78 °C disappearance                                          amine complete (based TLC). THF concentrated minimum volume                                          diluted CH2Cl2 washed H2O. aqueous layer extracted thoroughly
                                         CH2Cl2, dried Na2SO4 solvents evaporated dryness. residue                                          purified silica gel column chromatography yield h 76  yield. 1H NMR (DMSO-d6)
                                         δ 1.49 (s, 9H), 3.79 (s, 3H), 5.67 (dd, 1H, J = 10.16 2.34), 6.16 (dd, 1H J = 17.19,                                          2.34), 6.27–6.34 (m, 1H), 6.71 (d, 1H, J = 1.95), 7.34 (d, 1H, J = 1.95), 10.08 (s, br, 1H).

                                         4-Acrylamido-1-methyl-1H-pyrrole-2-carboxylic acid   solution h (1.032
                                         g, 4.12 mmol) CH2Cl2 (30 mL) added 1 M TiCl4 solution (10 mL, 10.31 mmol) 0
                                         °C. reaction mixture stirred slowly allowed come room temperature                                          complete disappearance starting material. reaction mixture diluted CH2Cl2
                                         washed H2O. aqueous layer extracted EtOAc organic solvent
                                         extracts pooled, dried Na2SO4 evaporated dryness yield 96   1H NMR
NIH-PA Author Manuscript




                                         (DMSO-d6) δ 3.81 (s, 3H), 5.67 (dd, 1H, J = 9.77 1.96), 6.17 (dd, 1H, J = 17.18                                          1.96), 6.29–6.35 (m, 1H), 6.71 (d, 1H, J = 1.95), 7.38 (d, 1H, J = 1.95), 10.09 (s, br, 1H),
                                         12.22 (s, br, 1H).

                                         4-Acrylamido-1 -methyl-N-(1-methyl-5-((1-methyl-5-(propylcarbamoyl)-1H-
                                         pyrrol-3-yl)carbamoyl)-1H-pyrrol-3-yl)-1H-pyrrole-2-carboxamide (j)                                          solution (217 mg, 1.12 mmol) HOBT (225 mg, 1.66 mmol) anhydrous CH2Cl2
                                         (20 mL) added Et3N (0.618 mL, 4.44 mmol) EDC (425 mg, 2.22 mmol). reaction
                                         mixture stirred room temperature 1 h N2, cooled amine f (505 mg, 1.66
                                         mmol) added CH2Cl2 (11 mL) containing Et3N (1 mL). reaction mixture stirred
                                         N2 18 h diluted CH2Cl2 washed H2O. aqueous layer
                                         extracted thoroughly CH2Cl2, dried Na2SO4 solvents evaporated.                                          residue purified silica gel column chromatography afford j 60  yield. 1H NMR


                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                               Page 5


                                          (DMSO-d6) δ 0.87 (t, 3H), 1.46–1.52 (m, 2H), 3.10–3.16 (m, 2H), 3.79 (s, 3H), 3.84 (s, 3H),
                                          3.85 (s, 3H), 5.67 (dd, 1H, J = 10.15 1.95), 6.19 (dd, 1H, J = 17.19 1.95), 6.34–6.41
                                          (m, 1H), 6.86 (d, 1H, J = 1.56), 6.94 (d, 1H, J = 1.56), 7.04 (d, 1H, J = 1.95), 7.18 (d, 1H, J =
NIH-PA Author Manuscript




                                          1.95), 7.25 (d, 1H, J = 1.95), 7.28 (d, 1H, J = 1.95), 8.0 (t, 1H, J = 5.47), 9.89 (s, 1H), 9.95
                                          (s, 1H), 10.12 (s, 1H).

                                          3-((1-Methyl-5-((1-methyl-5-((1-methyl-5-(propylcarbamoyl)-1H-pyrrol-3-
                                          yl)carbamoyl)-1H-pyrrol-3-yl)carbamoyl)-1H-pyrrol-3-yl)amino)-3-
                                          oxopropane-1-sulfonic acid (k) solution j (123 mg, 0.257 mmol) EtOH/
                                          H2O (4:1, 5.6 mL), added NaHSO3 solution (0.514 mmol, 55 mg 0.740 mL H2O).
                                          pH solution adjusted 8 reaction mixture refluxed 90 °C                                           complete disappearance starting material (based TLC). reaction cooled 0
                                          °C conc HCl added dropwise pH 1 2. solvent                                           evaporated dryness yield bright yellow solid treated cold 2 N HCl.                                           mixture centrifuged (4000 rpm, 10 min) supernatant decanted                                           remaining solid twice washed 2 N cold HCl, centrifuged supernatant
                                          decanted. remaining solid material thoroughly dried 93  k. 1H NMR
                                          (DMSO-d6) δ 0.87 (t, 3H), 1.44–1.53 (m, 2H), 2.53–2.57 (m, 2H), 2.66–2.70 (m, 2H), 3.09–
                                          3.15 (m, 2H), 3.79 (s, 3H), 3.83 (s, 3H), 3.84 (s, 3H), 6.85 (d, 1H, J = 1.56), 6.87 (d, 1H, J =
                                          1.56), 7.03 (d, 1H, J = 1.95), 7.15 (d, 1H, J = 1.56), 7.18 (d, 1H, J = 1.95), 7.24 (d, 1H, J =
                                          1.56), 8.0 (t, 1H, J = 6.48), 9.89 (s, 1H), 9.91 (s, 1H), 9.97 (s,1H).
NIH-PA Author Manuscript




                                          Methyl 3-(1-methyl-5-(1-methyl-5-(1-methyl-5-(propylcarbamoyl)-1H-pyrrol-3-
                                          yl)carbamoyl)-1H-pyrrol-3-yl)carbamoyl)-1H-pyrrol-3-ylamino)-3-
                                          oxopropane-1-sulfonate (l) solution k (129 mg, 0.229 mmol) dry dioxane
                                          (13 mL) added 3-methyl-1-p-tolyltriaz-1-ene (343 mg, 2.297 mmol). reaction                                           heated oil bath 80 °C ~ 4 h. dioxane reduced minimum volume                                           residue loaded Et3N deactivated silica gel column. product l (49 )                                           eluted EtOAc. 1H NMR (DMSO-d6) δ 0.87 (t, 3H), 1.46–1.52 (m, 2H), 2.74 (t, 2H, J =
                                          7.42), 3.10–3.15 (m, 2H), 3.62 (t, 2H, J = 7.42), 3.79 (s, 3H), 3.84 (s, br, 6H), 3.87 (s, 3H),
                                          6.86 (d, 1H, J = 1.57), 6.89 (d, 1H, J = 1.95), 7.03 (d, 1H, J = 1.95), 7.16–7.19 (m, 2H), 7.24
                                          (d, 1H, J = 1.95), 8.0 (t, 1H, J = 5.08), 9.89 (s, 1H), 9.93 (s, 1H), 10.07 (s, 1H). 13C NMR
                                          (150 MHz, DMSO-d6) 11.94, 23.08, 29.86, 36.39, 36.60, 36.64, 40.66, 44.50, 57.45, 104.39,
                                          104.55, 105.12, 118.14, 118.67, 118.92, 122.12, 122.53, 122.55, 123.24, 123.33, 123.56,
                                          158.82, 158.91, 161.70, 166.05. HR-MS (ES+H) m  calcd C25H34N7O7S: (576.2240).
                                           (576.2261).

                               DNA equilibrium binding studies
NIH-PA Author Manuscript




                                          Calf thymus DNA (CT-DNA), poly (deoxyadenylic–thymidylic) acid sodium salt [poly-
                                          d T)], netropsin distamycin purchased Sigma-Aldrich, St. Louis, MO.                                           stock solutions polymers prepared overnight dialysis 4 °C 10
                                          mM sodium phosphate buffer containing 1 mM Na2EDTA 10 percent EtOH pH 7.
                                          concentration stock CT-DNA poly-d T) solutions measured UV
                                          spectrophotometer using extinction coefficient ε260 = 6550 M−1 cm−1 ε260 =
                                          6500 M−1 cm−1 respectively. experimental purposes, compounds                                           dissolved respective buffers concentrations determined
                                          spectrophotometrically using extinction coefficients, ε296 = 21,500 M−1 cm−1 5, 6
                                          netropsin, ε303 = 34,000 M−1 cm−1 10, 11 distamycin.

                                          Thermal denaturation experiments carried Cary UV 300 Bio UV-visible
                                          Spectrophotometer (Varian , Palo Alto, CA) coupled Cary Temperature Controller
                                          unit. experiments performed using 1.4 mL cuvette (1 cm path length). 

                                            Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                                 Page 6


                                            melting CT-DNA poly-d T) monitored 260 275 nm temperature
                                            range 0 – 95 °C heating rate 0.5 °C/min data interval 0.2 °C                                             absence presence sulfones 5, 6, 10 11. melting temperature (TM) NIH-PA Author Manuscript




                                            determined analysis shape derivative melting curves.

                                            induced circular dichroism (ICD) titration compounds 5, 6, 10 11 CT-DNA
                                            poly-d T) performed Jasco-815 CD spectrometer (Jasco Corporation,
                                            Tokyo, Japan) equipped Jasco PTC-423S/15 Peltier Temperature Controller 
                                            point calibration CD spectrometer checked using 3.855 mM (1S)-(+)-10-
                                            camphorsulphonic acid. spectra solution 1 mm cuvette resulted ratio,
                                            ε191/ε291 = −2.00. experiments constant temperature 20 °C
                                            maintained help Julabo F25 refrigerated/heating circulator. spectrometer
                                            purged ~ 15 min N2 starting instrument ~ 30 min                                             light source attain stability starting experiments. serial dilution approach                                             ICD described Garbett et al.35 used titrate sulfone compounds (~ 10 – 50 μM)
                                            CT-DNA poly-d T) concentration range 1 nM 1 mM. approach,
                                            experiment started solution containing maximum concentration                                             DNA substrate serially diluting solution cuvette ligand stock
                                            solution concentration cuvette achieve required concentration
                                            range DNA substrate, titrating DNA substrate constant ligand
                                            concentration. semi-microcuvette non-transmitting black walls 1 cm path
NIH-PA Author Manuscript




                                            length used experiments. spectra scanned 400 220 nm                                             data pitch 0.1 nm, scan speed 100 nm/min 1 sec response time 1 nm
                                            bandwidth. spectrum buffer subtracted final plot taken average                                             accumulated scans. binding curve obtained plotting maxima                                             induced CD signal sulfone compounds function logarithm DNA
                                            substrate concentration. binding constant calculated evaluating slope                                             graph using non-linear fit option Origin/FitAll software previously described.35

                               DNA methylation
                                            CT DNA (100 μM, nucleotide), dialyzed overnight 10 mM sodium cacodylate buffer
                                            (pH 7.0) reacted room temperature 24 h methylating compounds (dissolved
                                            minimal volume ice-cold 95  EtOH) final concentrations 1, 5, 10, 100 μM                                             10 mM sodium cacodylate buffer (pH 7.0) total volume 2 mL  1, 5 10 μM
                                            alkylating agent) 1 mL  100 μM alkylating agent). DNA precipitated                                             reaction solution 3 M NaOAc (pH 4.8) EtOH, redissolved 10 mM
                                            sodium cacodylate buffer (pH 7.0) total volume 500 μL heated 30 min 90
                                            °C release N3- N7-alkylpurines. partially apurinic DNA precipitated 0 °C
                                            adding 50 μL cold 0.1 N HCl. supernatant containing N-methylpurines NIH-PA Author Manuscript




                                            analyzed HPLC. measurement 3-mA, following conditions utilized:
                                            column, Partisil 10 SCX; temperature, 25 °C; eluent, 175 mM ammonium formate (pH 3.0)
                                            containing 30  (v/v) MeOH; flow rate, 1 mL/min; detection, UV 270 nm.                                             simultaneous measurement 3-mA 7-methylguanine (7-mG), following
                                            conditions utilized: Syngeri Fusion-RP column (temperature, 25 °C; eluent, 50 μM
                                            ammonium formate (pH 4.0) containing 2  (v/v) isopropanol; flow rate, 1.25 mL/min;
                                            detection, UV 270 280 nm). Authentic standards 3-mA 7-mG used                                             HPLC identification adducts calculate response factors.

                               E. coli cytotoxicity assays
                                            Cultures Escherichia coli strains AB1157 (strr, wild type) GC4803 (alk−/− tag−/−
                                            kanr, DNA repair mutant) started frozen stocks, liquid LB media                                             corresponding antibiotic. Overnight cultures strains used seed 10 mL LB


                                             Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                             Page 7


                                           medium cells allowed grow 2–3 h reached mid-log growth stage
                                           (OD600 = 0.5). Cells harvested 1 mL aliquots centrifugation (5000 × g, 5 min),
                                           washed phosphate buffered saline (PBS) resuspended 950 μL PBS. Pre-weighed
NIH-PA Author Manuscript




                                           aliquots compounds dissolved 95  EtOH 1 M stock. Dilutions                                            stock used confirm concentration compound solution UV absorbance.
                                           Depending observed concentration, stock solution alkylating agent diluted                                            appropriate volumes 95  EtOH obtain working stocks 40, 80, 120, 160 200
                                           μM. 50 μL stock solution added 950 μL previously prepared cell
                                           suspension  1x PBS) mixed vortexing. cells treated methylating
                                           compounds 1 h 37 °C. control set included cells treated similarly
                                           5  EtOH 1x PBS. Post treatment, cells harvested centrifugation, rinsed
                                           1x PBS, serially diluted (100 – 10−6) 1x PBS plated solid LB media                                            appropriate antibiotic. 16 h, colonies counted plate cell viability
                                           (survival  ) calculated relative control set.

                               T98G Glioma cell cytotoxicity assay
                                           Human glioblastoma cells (T98G) maintained growth medium, e., Eagle’s
                                           Minimum Essential Medium (EMEM) 10  fetal bovine serum (FBS), 50 μg μL-1
                                           gentamycin, 1x MEM non-essential amino acids 1 mM sodium pyruvate. evaluate
                                           short term cytotoxicity measuring viable cells, T98G cells maintained growth medium
                                           harvested Trypsin-EDTA treatment, resuspended fresh growth medium NIH-PA Author Manuscript




                                           density 104 cells mL−1, 200 μL (2 × 103 cells) suspension seeded                                            wells sterile 96 tissue culture microplate. cells allowed attach                                            grow 24 h, treated serial dilutions drug 72 h. treatment,
                                           viable cells measured using MTS assay using CellTiter 96 AQueous kit
                                           (Promega) manufacturer’s instructions. assay long-term cytotoxicity, cells                                            grown approximately 50–75  confluence trypsinized counted using                                            CASY counter manufacturer’s instructions. Cells seeded 96 plates                                            density 120 cells incubated 37 °C 24 h. cells treated 1                                            incubated 9 days 37 °C. Plates removed fluorescence determined using
                                           CyQuant kit (Invitrogen, #C7026) following manufacturer’s instructions. Results
                                           average separate experiments normalized vehicle treated control cells
                                           error bars representing standard error mean, previously described.35

                               Quantification aldehyde reactive sites (ARS)
                                           T98G cells maintained growth medium, harvested Trypsin-EDTA treatment,
                                           resuspended fresh growth medium density 2.5 × 105 cells/mL, 2 mL (5 × 105
                                           cells) suspension seeded wells sterile 6 tissue culture plate.
NIH-PA Author Manuscript




                                           Cells allowed grow 24 h, treated various compounds different time
                                           points different concentrations. end treatment, adherent cells                                            harvested trypsin-EDTA treatment pooled cells culture supernatant.
                                           Pooled cells suspension pelleted centrifugation, washed 1x PBS                                            genomic DNA isolated using DNAzol reagent (Invitrogen). DNA solution                                            quantified UV absorbance 260 nm using Synergy H1 multiwell plate reader (BioTek,
                                           Winooski, VT). ARS purified DNA reacted biotin-conjugated
                                           aldehyde reactive probe, immobilized 96 ELISA plates, detected using
                                           horseradish peroxidase (HRP)-conjugated streptavidin using colorimetric substrate                                            manufacturer’s instructions (Dojindo Molecular Technologies, Rockville, Maryland).




                                             Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                                Page 8


                               Markers Apoptosis
                                            T98G cells maintained growth medium, harvested Trypsin-EDTA treatment,
                                            resuspended fresh growth medium seeded 96- 6 plates assay
NIH-PA Author Manuscript




                                            requirements:   measure PARP activity, 2 × 104 cells seeded wells 96
                                            plate, (ii) measure PARP cleavage, 104 cells seeded wells 96                                             plate, (iii) measure caspase-3 -7 activities, 106 cells seeded wells                                             6 plate. Cells allowed grow 24 h, treated compounds different
                                            time periods different concentrations. end treatment, adherent cells
                                            harvested trypsin-EDTA treatment pooled cells supernatant.                                             PARP activity determined measuring deposition PAR immobilized
                                            histones using anti-PAR (primary antibody) horseradish peroxidase (HRP) conjugated
                                            secondary antibody (Trevigen , Gaithersburg, MD). PARP cleavage measured using
                                            anti-cleaved PARP (primary antibody) HRP-conjugated secondary antibody (Thermo
                                            Fisher Scientific, Pittsburgh, PA). Intracellular capase-3 -7 activities measured
                                            using DEVD-AMC (benzyloxycarbonyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin),                                             synthetic fluorogenic substrate cysteine proteases, caspase-3 -7 (Invitrogen,
                                            Carlsbad, CA).

                               Microfluidic-assisted replication tract analysis
                                            Human glial SF767 tumor cells incubated 50 μM iododeoxyuridine (IdU) label
NIH-PA Author Manuscript




                                            active replication forks.36 removal IdU, cells incubated 50 μM
                                            chlorodeoxyuridine (CldU) presence solvent 1 (5 10 μM). DNA                                             cells isolated loaded microcapiliaries immunostained antibodies
                                            specific halogenated pyrimidines. capillaries examined                                             fluorescent microscope equipped digital camera locate areas optical density
                                            alignment. fields selected photographed twice different filters                                             obtain 2 color images. Approximately 50–80 images taken 3–4 micro channels                                             sample order collect 300–400 replication tracks. Track lengths measured
                                            using AxioVision image analysis software. criteria collecting image data track
                                            DNA density track alignment; tracks containing 3 labeled segments (e.g., green-
                                            red-green) likely present merging forks adjacent replicons                                             included.

                               RESULTS
                               Synthesis
                                            syntheses sulfonate ester sulfone analogues di- tri-peptide minor
                                            groove binders different C-terminus groups (Figure 1) generally followed
NIH-PA Author Manuscript




                                            previously published procedures13 modifications described Experimental
                                            Procedures Supporting Information.

                               Methylation DNA
                                            yields 3-mA result incubating different concentrations compounds 1–4,
                                            7 8 CT-DNA 24 h room temperature pH 7.0 sodium cacodylate buffer                                             shown Figure 2A. 2-ring compounds, methoxyethyl (3)                                             methoxyethoxyethyl (4) ethers yielded lowest 3-mA, difference
                                            2-ring compounds evident highest (100 μM)
                                            concentration. appears compounds polar C-terminal sidechains                                             weaker methylating activity hydrophobic propyl allyl groups.
                                            tripeptide propyl (7) allyl (8) compounds clear concentration response 


                                             Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                               Page 9


                                          3-mA adduct observed 1 μM concentration. Analogue 8 allyl
                                          terminus active compound.
NIH-PA Author Manuscript




                                          preference dipetide 1 tripeptide 7 minor groove vs. major groove alkylation
                                          assessed comparing relative yields 3-mA 7-mG (Figure 2B, Table 1).                                           1 5 μM concentrations, ratio averages > 100:1 minor major groove                                           compounds. 10 100 μM concentration, 3-mA 7-mG ratio drops                                           approximately 60:1 dipetide 1, remains > 100:1 tripeptide 7.  DNA
                                          methylation compounds essentially restricted formation 3-mA.                                           contrasts 1:10 3-mA 7-mG ratio observed MMS related methylating
                                          agents.

                               DNA equilibrium binding
                                          approaches used probe relationship DNA methylation                                           different minor groove binders equilibrium binding DNA using sulfone
                                          derivatives 5, 6, 10, 11. sulfonate esters relatively reactive (t1/2 ~ 6 h pH 7
                                          buffer, Supporting Information) converted sulfonate anion transfer
                                          methyl group nucleophile. sulfones isosteric, neutral stable solution.
                                          Initial attempts use isothermal titration calorimetry (ITC) thwarted                                           limited solubility compounds aqueous buffer low heats liberated
                                          binding.
NIH-PA Author Manuscript




                               UV melting studies
                                          UV extinction coefficient DNA function temperature related thermal
                                          stability duplex DNA. effect 5, 6, 10 11 thermal stability CT-DNA
                                          poly-(dA-dT) determined monitoring absorbance 260 nm calculating                                           mid-point melting temperature (TM). Ligands bind double stranded DNA generally
                                          stabilize duplex increase TM. summarization effect                                           compounds thermal stability CT-DNA poly-d T) given Table 2. 2-
                                          ring compounds 5 6 showed minimal increase stability ΔTM 0.4 °C                                           CT-DNA 1.2 °C poly-d T). 3-ring compounds 10 11                                           stabilizing: ΔTM 1.1 °C 10 11 CT-DNA 4.1 °C 10 4.7 °C 11
                                          poly-d T). comparison, netropsin distamycin raise TM CT-DNA                                           21.1 °C 17.0 °C, poly-d T) 40.6 °C 36.9 °C respectively.

                               Induced CD studies
                                          2- 3-ring peptide compounds achiral optically inactive.                                            interaction DNA, ligands acquire induced-CD (ICD) signal coupling
NIH-PA Author Manuscript




                                          electric transition moments ligand chiral double helix. induced Cotton
                                          effect distinct DNA CD spectrum directly reflects ligand-DNA
                                          interaction.35 CD titration netropsin, distamycin tripeptides 10 11 CT-
                                          DNA poly-d T) represented Figure 3 corresponding values                                           binding constants reported Table 2. absence minor groove binding
                                          compounds, CT-DNA shows positive band 278 nm negative band 245.2 nm                                           concentration 148 μM (Supporting Information). Similarly, poly-d T) shows positive
                                          band 166 nm negative band 246.9 nm concentration 143 μM (Supporting
                                          Information). Titration 10 μM netropsin CT-DNA poly-d T) shows ICD
                                          spectrum 320 nm gives binding constant (Kb) 1.95 × 105 M−1 2.44 × 105
                                          M−1, respectively (Table 1, 5 6Figure 3A,C). Interaction 10 μM dipeptides CT-
                                          DNA poly-d T) concentration range 1 nM 1 mM did rise                                           ICD signal (data shown).  binding 2-ring compounds DNA


                                            Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                               Page 10


                                            substrates weak experimentally determined methods attempted.
                                            interaction CT-DNA, tripeptides 10 11 10 μM showed positive signal                                             325 nm (Figure 3E-H). signal saturated 1 mM CT-DNA giving Kb 2.88 × 104
NIH-PA Author Manuscript




                                            M−1 3.16 × 104 M−1, respectively 10 11 (Figure 3E,G). interaction                                             compounds 10 11 poly-d T), value binding constant                                             1.95 × 104 1.81 × 104 325 nm, respectively (Figure 3F,H).

                                            understand higher binding affinity provided extra pyrrolecarboxamide unit                                             tripeptides effect positively charged, ICD maxima                                             interactions distamycin (10 μM) CT-DNA poly-d T) (Figure 3B,D)                                             measured compared netropsin (Figure 3A,C) tripeptides 10 11. Kb
                                            distamycin calculated 2.10 × 105 M−1 5.13 × 105 M−1 CT-DNA                                             poly-d T), respectively.  introduction single electrostatic interaction                                             distamycin tripeptide C-terminal guanidinium group results approximately                                             10-fold increase binding affinity vs. neutral molecules 7 8. extra cationic
                                            amidinium group N-terminus netropsin dipeptide vs. distamycin, compensates
                                            pyrrolecarboxamide subunit; compounds similar affinities                                             DNA.

                               Toxicity E. coli
                                            toxicities di- tri-peptide methylating agents evaluated WT E. coli NIH-PA Author Manuscript




                                            Alka/Tag double mutant (Figure 4). defective known
                                            bacterial DNA-glycosylases excise 3-mA. compounds toxicity                                             10 μM concentration WT bacteria. Presumably, efficient BER protects WT cells
                                            low levels alkylation damage. glycosylase double mutant cell, toxicity
                                            profiles 2-ring analogs quite similar, correlates vitro formation
                                            3-mA different compounds (Figure 2A). tripeptide analogs, toxicities
                                            followed order allyl (8) > propyl (7) > methoxyethyl (9). tripeptides                                             2.5–3.0 orders magnitude toxic corresponding dipeptide compounds.                                             correlates vitro adduct data 7 8 (Figure 2A).

                               Toxicity T98G human glioma cells
                                            toxicity 1 7 compared WT T98G glioma cells using short term (72 h)
                                            MTS assay (Figure 5). Tripeptide 7 (LD50 19 μM) > 10-fold toxic dipeptide
                                            1 (LD50 246 μM). Comparative toxicity experiments performed 1 WT T98G
                                            cells, cells engineered express (MPG+) express (MPG-) human
                                            MPG glycosylase mediates excision 3-mA BER (Figure 6). 
                                            expressing cells, 10-fold increase MPG mRNA significant increase
NIH-PA Author Manuscript




                                            protein expression.28 MPG knockdown T98G cells, expression MPG <5 
                                            WT cells.32 significant difference toxicity 1 WT
                                            MPG+ cells (LD50 ~240 μM).  MPG- cells 60  sensitive
                                            relative WT MPG+ cells (LD50 140). differences toxicity parallel activation
                                            PARP formation ARS  .

                               Formation aldehyde reactive sites (ARS)
                                            apparent combined rates formation elimination abasic sites 5′-p-dR strand
                                            breaks monitored WT, MPG+ MPG- T98G cells treated equitoxic
                                            concentrations 1 (80 μM) 7 (7 μM). concentrations based                                             toxicity short-term assay WT cells (Figure 5). aldehyde reactive hydrazine
                                            probe37–39 biotin-conjugated horseradish peroxidase (HRP)-conjugated
                                            streptavidin (Figure 7) used label ring-opened aldehyde form abasic sites, 

                                              Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                              Page 11


                                           aldehyde groups present. level aldehyde reactive sites
                                           (ARS) correlate formation ring-opened form 1′-hydroxy-2′-
                                           deoxyribose group abasic sites 5′-p-dR termini.40 limits detection, NIH-PA Author Manuscript




                                           background levels just 0.5   DMSO cell lines. initial rate
                                           formation  6 h) ARS 1 7 WT cells similar MPG+ cells
                                           indicating glycosylase excision 3-mA limiting WT cells.  total
                                           ARS sustained time period monitored virtually dipeptide 1                                            tripeptide 7 equitoxic concentrations. anticipated, MPG- cells respond differently:
                                           rate formation ARS slower sustained level ARS 12 h time
                                           course reaches 50  observed WT MPG+ cells.

                                           mentioned  compounds 1 7 compared WT, MPG+                                            MPG- T98G cells using equitoxic concentrations WT cells. number                                            WT cells cytotoxicity assay 1 × 104 cells/mL, ARS assay                                            concentration 25 × 104 cells/mL, toxicity significantly lower                                            dilution methylating agent 25-fold cells. addition, markers apoptosis,
                                           e.g., caspase-3 -7, appear elevated 12 h 250 μM
                                           concentration, LD50 toxicity assay (Figure 5).  unlikely
                                           significant percentage ARS measured dead cells.

                               PARP activation cleavage
NIH-PA Author Manuscript




                                           PARP rapidly binds single-strand breaks, 5′-p-dR termini produced                                            BER, synthesizes poly(ADP-ribose) chains.41–43 time course PARP activation                                            repair 3-mA reflects stage BER APE-1 produces strand break 5′                                            abasic site created MPG, lyase activity.  time course                                            PARP activation somewhat delayed relative ARS formation. Little activation                                            PARP observed treating WT T98G cells 80 μM 1 (Figure 8A).                                            concentration corresponds LD10 short-term toxicity assay (Figure 5A). 250
                                           μM, corresponds LD50 concentration, PARP activation reached maximum
                                           level 12 h remained elevated 18 h (Figure 8A).

                                           PARP activation 1 compared cell lines. WT MPG+ cells treated
                                           1 dose-dependent increase PAR deposition vs. untreated cells. 
                                           little change observed MPG- knocked cells treated 1 (Figure 9).                                            data consistent anticipated reduced rate 3-mA lesions converted                                            AP sites MPG (Figure 7) subsequent APE1 mediated formation 5′-dRP
                                           termini, substrates PARP.

                                           Caspase-3 -7 activation, associated apoptosis, results inactivation NIH-PA Author Manuscript




                                           PARP.44–46  caspase activity monitored WT cells treatment                                            80 250 μM 1 (Figure 8B). Caspase activation, starts climb 12 h                                            continued rise 18 h, observed 250 μM concentration 1
                                           indicating 80 μM concentration toxic assay conditions.                                            predicted, cleavage PARP significant concentration 1 induces
                                           caspase activation (Figure 8C). Little effect seen lower concentration 1.

                               Replication tract analysis
                                           vitro evidence 3-mA, subsequent BER intermediates, block
                                           DNA replication.23–26 verify case cells, microfluidic-assisted
                                           replication tract analysis36 performed SF767 glioma cells treated 5 10
                                           μM 1. assay uses antibodies measure length replication tracts                                            exposure cells alkylating agent 1 monitoring 5-iodo-dU incorporation 

                                             Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                              Page 12


                                          exposure 1 monitoring 5-chloro-dU incorporation. agent blocks replication,                                           length DNA stained 5-chloro-dU antibody shortened. 40 min
                                          exposure glioma cells 5 μM 1 reduces clonogenic survival 35 . results
NIH-PA Author Manuscript




                                          appear Figure 10 track length 50 percentile reduced 7 μm
                                          untreated control cells 5.7 4.0 5 10 μM concentrations 1 (statistical
                                          difference p = 0.001). data provide evidence formation 3-mA directly,
                                          indirectly BER intermediates, impedes replication fork progression.

                               DISCUSSION
                               Relationship DNA Methylation DNA Binding
                                          Methylating agent 1 developed strategy selectively efficiently generate 3-
                                          mA lesions vitro vivo.13–18 approach works quite                                           sought improve design. note weak equilibrium binding                                           initially synthesized 2-ring compound. Despite weak binding,18 alkylation pattern
                                          1 different non-equilibrium binding methylating agents, e.g., methyl
                                          methanesulfonate (MMS), predominantly yield major groove adduct N7-
                                          methylguanine (7-mG).47 vitro ratio 3-mA (minor groove) 7-mG (major
                                          groove) approximately 3-orders magnitude higher 1 7 vs. MMS. methylation
                                          DNA 1 clearly driven dipeptide binding minor groove T rich
                                          regions delivering methyl group sulfonate ester.13,16–19 current
NIH-PA Author Manuscript




                                          study, efforts enhance methylating activity changing C-terminal group improve
                                          water solubility DNA binding, successful. major improvement came
                                          adding N-methylpyrrolecarboxamide subunit. summary, dipeptides                                           binding affinities 1 mM. extra pyrrole subunit tripeptides, provides
                                          additional H-bond VDW contact, displaces additional minor groove waters,
                                          increases binding 10-fold. despite higher binding
                                          affinity tripeptides DNA higher levels 3-mA produce (Figure
                                          2A), ratio minor major groove methylation does radically differ (Figure 2B).
                                          lack strong correlation specificity minor groove methylation                                           minor groove binding affinity suggest dipeptides preferentially populate                                           minor groove T sequences, make organized enthalpic interactions (H-
                                          bonds, VDW contacts) required detection ICD, isothermal titration calorimetry (ITC)
                                          TM experiments.

                               Mechanism Action
                                          toxicity alkylating compounds used present study highly associated
                                          yield 3-mA, remains unclear lesion directly responsible NIH-PA Author Manuscript




                                          biological effects seen cells. explore mechanism(s) responsible                                           toxicity, compounds evaluated WT alkA/tag glycosylase null E. coli cells.
                                          expected, WT cells insensitive relative alkA/tag mutant efficient
                                          BER 18 implies failure initiate BER leads persistent toxic 3-
                                          mA adducts. previously reported alkA/tag mutant sensitive                                           dipeptide 1 cells defective AP endonuclease activity (apn null cells) suggesting                                           3-mA deleterious abasic site downstream BER intermediates.17,18
                                          toxicity 1 explored WT S. cerevisiae Mag1 glycosylase mutant
                                          (mag1), AP endonuclease double mutant (apn1apn2) BER triple mutant
                                          (mag1apn1apn2).20 apn1apn2 mutant somewhat sensitive toxicity 1
                                          mag1 cells, triple mutant sensitive. mag1rad14 double
                                          mutant yeast turned surprisingly sensitive 1 mag1apn1apn2 triple
                                          mutant, rad14 single mutant showed phenotype. suggests important role



                                           Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                              Page 13


                                         nucleotide excision repair point processing 3-mA, initial
                                         glycosylase step BER blocked (Figure 11).
NIH-PA Author Manuscript




                                         story human cells similar E. coli yeast. T98G MPG- glioma
                                         cells, human MPG protein excises 3-mA knocked 95 ,32                                          60  sensitive toxicity 1 vs. WT MPG+ cells. inverse
                                         correlation expression enzyme removes 3-mA toxicity 1                                          consistent ARS data. MPG- cells significantly lower rates formation
                                         sustained levels ARS WT cells. yield 3-mA adducts produced
                                         1 7 dependent MPG levels, assumed                                          unrepaired 3-mA lesions MPG- cells. account lower ARS levels
                                         observed cells.

                                         fate unrepaired 3-mA adducts MPG- cells unknown;                                           enhanced toxicity 1 MPG knockdown cells indicates 3-mA                                          converted process lethal intermediate 3-mA directly blocks polymerases                                          replication forks. 3-mA spontaneously depurinate, especially single-stranded DNA,                                          yield AP site. case, APE1 cleavage AP site cause PARP
                                         activation similar WT. observed. know 1 causes replication blocks                                          glioma cells exposed low concentrations 1 microfluidic-assisted replication
                                         tract analysis cells treated 1 40 min (Figure 10). direct effect NIH-PA Author Manuscript




                                         indirect effect 3-mA remains determined, previously demonstrated
                                         3-mA stable analogue, 3-methyl-3-deazaadenine, directly block DNA
                                         polymerization vitro.24–26

                                         significant sensitizing effect DNA methylating agents methyl methanesulfonate
                                         (MMS) (4-fold increase) temozolomide (10-fold increase) reported human
                                         mammary gland cells express MPG.48 expression catalytically defective
                                         MPG mutant did sensitize cells MMS temozolomide indicating                                          involvement glycosylase activity. contrast, toxicity 1 MPG 
                                         expressing cells enhanced vs. WT cells.48 expected, expression MPG
                                         caused significant increase rate repair 7-mG (3-mA levels followed)
                                         MMS treatment. authors suggested increase toxicity MPG
                                         mediated conversion innocuous 7-mG lesions toxic BER intermediates, e.g., abasic
                                         sites. cell lines expressing MPG sensitive MMS.49 similar
                                         modulation MMS toxicity mutagenicity reported CHO cells express
                                         rat MPG protein.50 understand cellular level MPG does affect                                          toxicity 1 MMS way, important note equitoxic
                                         concentrations MMS 1 (based toxicity WT cells), yield 7-mG
NIH-PA Author Manuscript




                                         adducts substantially higher MMS 1. difference
                                         ratio 7-mG (non-toxic) 3-mA (toxic): approximately 10:1 MMS47 1:100
                                         1. conversion non-toxic 7-mG toxic intermediates BER nicely explains                                          differential impact MPG expression MMS vs. 1.48

                                         level ARS function APE-1 endonuclease activity converts abasic sites
                                         5′-p-dR lesions, retain reactive aldehyde functionality (Figure 11).                                          number APE-1 molecules cells estimated 4–70 × 105 cell,51
                                         Pol β, APE-1 MPG, normally considered rate limiting step BER.52
                                          antisense supression MPG APE-1 enhances toxicity 1 suggesting                                          unrepaired 3-mA cytotoxic.53 shown using small molecule inhibitor                                          APE-1 level persistence ARS WT T98G cells continues increase
                                         12 h treatment 1,54 level falls 6 h cells treated 1
                                         (Figure 7). inhibition APE-1 endonuclease activity synergistically enhanced 

                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                                            Page 14


                                           toxicity 1 T98G cells consistent toxicity unrepaired abasic sites. Clearly,
                                           unrepaired 3-mA, abasic sites BER intermediates cytotoxic.
NIH-PA Author Manuscript




                                           summary, number minor groove alkylating compounds prepared evaluated
                                           based ability bind  methylate DNA. expected, direct
                                           relationship DNA binding, formation 3-mA toxicity.  rate                                            extent excision 3-mA human MPG formation ARS inversely correlate
                                           toxicity. data indicate 3-mA directly cause toxicity, likely                                            ability block DNA replication, need converted                                            downstream BER intermediate.

                               Supplementary Material
                                           Refer Web version PubMed Central supplementary material.


                               Acknowledgments
                                           gratefully acknowledge Julia Sidorova (Department Pathology, University Washington) support
                                           guidance microfluidic-assisted replication tract analysis assay.

                                           FUNDING
NIH-PA Author Manuscript




                                           work supported National Institutes Health grants CA29088 (BG), CA148629 (RWS)                                            GM087798 (RWS). Support UPCI Lentiviral Facility provided Cancer Center Support Grant
                                           CA047904 National Institutes Health.


                               ABBREVIATIONS

                                         AlkA             E. coli 3-methyladenine-DNA glycosylase II
                                         ARS              aldehyde reactive site
                                         BER              base excision repair
                                         CD               circular dichroism
                                         ICD              induced circular dichroism
                                         ITC              isothermal titration calorimetry
                                         3-mA             N3-methyladenine
                                         7-mG             N7-methylguanine
                                         MPG              (aka, AAG) methylpurine-DNA glycosylase
NIH-PA Author Manuscript




                                         MPG+             MPG overexpressing T98G cells
                                         MPG-             MPG knockdown T98G cells
                                         PARP             poly(ADP-ribose)polymerase
                                         TAG              E. coli 3-methyladenine DNA glycosylase                                          WT               wild type

                               References
                                           1. Pratt, WB.; Ruddon, RW.; Ensminger, WD.; Maybaum, J., editors. Anticancer Drugs. 2. Oxford
                                              Press; New York: 1994.
                                           2. http://monographs.iarc.fr/ENG/Classification/




                                               Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                                 Page 15


                                         3. Shrivastav N, Li D, Essigmann JM. Chemical biology mutagenesis DNA repair: cellular
                                            responses DNA alkylation. Carcinogenesis. 2010; 31:59–70. [PubMed: 19875697]
                                         4. Marchesi F, Turriziani M, Tortorelli G, Avvisati G, Torino F, Vecchis L. Triazene compounds:
NIH-PA Author Manuscript




                                            mechanism action related DNA repair systems. Pharmacol Res. 2007; 56:275–287.
                                            [PubMed: 17897837]
                                         5. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC,
                                            Rubnitz JE, Sandlund JT, Rivera GK, Evans  Relling MV, Pui CH. Cumulative incidence                                             secondary neoplasms event childhood acute lymphoblastic leukemia. J Med
                                            Assoc. 2007; 297:1207–1215.
                                         6. Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia secondary malignancy                                             children adolescents: current findings issues. Cancer. 2009; 115:23–35. [PubMed:
                                            19072983]
                                         7. Türk D, Szakács G. Relevance multidrug resistance age targeted therapy. Curr Opin
                                            Drug Discov Devel. 2009; 12:246–252.
                                         8. Baumert C, Hilgeroth  Recent advances development P-gp inhibitors. Anticancer Agents
                                            Med Chem. 2009; 9:415–436. [PubMed: 19442042]
                                         9. Gangemi R, Paleari L, Orengo  Cesario  Chessa L, Ferrini S, Russo P. Cancer stem cells:                                             new paradigm understanding tumor growth progression drug resistance. Curr Med
                                            Chem. 2009; 16:1688–1703. [PubMed: 19442140]
                                         10. Baguley BC. Multiple drug resistance mechanisms cancer. Mol Biotechnol. 2010; 46:308–316.
                                              [PubMed: 20717753]
NIH-PA Author Manuscript




                                         11. Liu J, Powell KL, Thames HD, MacLeod MC. Detoxication sulfur half-mustards                                               nucleophilic scavengers: robust activity thiopurines. Chem Res Toxicol. 2010; 23:488–496.
                                              [PubMed: 20050632]
                                         12. Abel EL, Bubel JD, Simper MS, Powell L, McClellan SA, Andreeff M, MacLeod MC, DiGiovanni
                                              J. Protection 2-chloroethyl ethyl sulfide (CEES)-induced cytotoxicity human
                                              keratinocytes inducer glutathione detoxification pathway. Toxicol Appl Pharmacol.
                                              2010; 255:176–183. [PubMed: 21723306]
                                         13. Zhang Y, Chen FX, Mehta P, Gold B. design groove sequence selective alkylation                                               DNA sulfonate esters tethered lexitropsins. Biochemistry. 1993; 32:7954–7965. [PubMed:
                                              8394120]
                                         14. Encell L, Shuker DEG, Foiles PG, Gold B. vitro methylation DNA minor groove
                                              binding methyl sulfonate ester. Chem Res Toxicol. 1996; 9:563–567. [PubMed: 8728498]
                                         15. Kelly J, Shah D, Chen FX, Wurdeman R, Gold B. Quantitative qualitative analysis DNA
                                              methylation N3-adenine N-methyl-N-nitrosourea dimethyl sulfate. Chem Res Toxicol.
                                              1998; 11:1481–1486. [PubMed: 9860491]
                                         16. Varadarajan S, Shah D, Dande P, Settles S, Chen FX, Fronza G, Gold B. DNA damage                                               cytotoxicity induced minor groove binding methyl sulfonate esters. Biochemistry. 2003;
                                              42:14318–14327. [PubMed: 14640700]
                                         17. Shah D, Gold B. Evidence Escherichia coli N3-methyladenine lesions cytotoxicity
NIH-PA Author Manuscript




                                              induced minor groove binding methyl sulfonate ester modulated vivo netropsin.
                                              Biochemistry. 2003; 42:12610–12616. [PubMed: 14580207]
                                         18. Shah S, Kelly J, Zhang Y, Dande P, Martinez J, Ortiz G, Fronza G, Tran H, Soto MA, Marky L,
                                              Gold B. Evidence Escherichia coli N3-methyladenine lesions induced minor groove
                                              binding methyl sulfonate ester processed base nucleotide excision repair.
                                              Biochemistry. 2001; 40:1796–1803. [PubMed: 11327842]
                                         19. Kelly J, Inga  Chen FX, Dande P, Shah D, Monti P, Aprile  Burns PA, Scott G, Abbondandolo
                                               Gold B, Fronza G. Relationship DNA methylation mutational patterns induced                                               sequence selective minor groove methylating agents. J Biol Chem. 1999; 274:18327–18334.
                                              [PubMed: 10373436]
                                         20. Monti PA, Campomenosi P, Iannone R, Ciribilli Y, Iggo R, Scott G, Burns PA, Shah D, Menichini
                                              P, Abbondandolo  Gold B, Fronza G. Influences base excision repair defects lethality
                                              mutagenesis induced lex, sequence selective N3-adenine methylating agent. J Biol
                                              Chem. 2002; 277:28663–28668. [PubMed: 12042310]


                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                                    Page 16


                                         21. Monti P, Iannon R, Campomenosi P, Ciribilli Y, Robbiano  Varadarajan S, Shah D, Menichini
                                              P, Gold B, Fronza G. Nucleotide excision repair defect influences lethality mutagenicity
                                              induced lex, sequence-selective N3-adenine methylating agent absence base
NIH-PA Author Manuscript




                                              excision repair. Biochemistry. 2004; 43:5592–2299. [PubMed: 15134433]
                                         22. Monti P, Ciribilli Y, Russo D, Bisio  Perfumo C, Andreotti V, Menichini P, Inga  Huang X,
                                              Gold B, Fronza G. REV1 Polζ influence toxicity mutagenicity lex, sequence
                                              selective N3-adenine methylating agent. DNA Repair. 2008; 7:431–438. [PubMed: 18182332]
                                         23. Boiteux S, Huisman O, Laval J. 3-Methyladenine residues DNA induce SOS function sfiA                                               Escherichia coli. EMBO J. 1984; 3:2569–2573. [PubMed: 6239774]
                                         24. Larson K, Sahm J, Shenkar R, Strauss B. Methylation-induced blocks vitro DNA replication.
                                              Mutat Res. 1985; 150:77–84. [PubMed: 4000169]
                                         25. Plosky BS, Frank  Berry DA, Vennall GP, McDonald JP, Woodgate R. Eukaryotic Y-family
                                              polymerases bypass 3-methyl-2′-deoxyadenosine analog vitro methyl methanesulfonate-
                                              induced DNA damage vivo. Nucleic Acids Res. 2008; 36:2152–2162. [PubMed: 18281311]
                                         26. Settles Wang R-W, Fronza G, Gold B. Effect N3-Methyladenine isosteric stable
                                              analogue DNA polymerization. J Nucleic Acids. 2010:426505. [PubMed: 20936169]
                                         27. Monti P, Broxson C, Inga  Wang RW, Menichini P, Tornaletti S, Gold B, Fronza G. 3-Methyl-3-
                                              deazaadenine, stable isostere N3-methyl-adenine, efficiently bypassed replication vivo
                                              transcription vitro. DNA Repair. 2011; 10:861–868. [PubMed: 21676659]
                                         28. Tang JB, Svilar D, Trivedi RN, Wang XH, Goellner EM, Moore B, Hamilton RL, Banze LA,
                                              Brown AR, Sobol RW. N-methylpurine DNA glycosylase DNA polymerase beta modulate
NIH-PA Author Manuscript




                                              BER inhibitor potentiation glioma cells temozolomide. Neuro Oncol. 2011; 13:471–486.
                                              [PubMed: 21377995]
                                         29. [Tang J, Goellner EM, Wang XW, Trivedi RN, St Croix CM, Jelezcova E, Svilar D, Brown AR,
                                              Sobol RW. Bioenergetic metabolites regulate base excision repair-dependent cell death response
                                              DNA damage. Mol Cancer Res. 2010; 8:67–79. [PubMed: 20068071]
                                         30. Mutamba JT, Svilar D, Prasongtanakij S, Wang XH, Lin YC, Dedon PC, Sobol RW, Engelward
                                              BP. XRCC1 base excision repair balance response nitric oxide. DNA Repair. 2011;
                                              10:1282–1293. [PubMed: 22041025]
                                         31. Svilar D, Vens C, Sobol RW. Quantitative, real-time analysis base excision repair activity cell
                                              lysates utilizing lesion-specific molecular beacons. J Vis Exp. 2012; 66:e4168. [PubMed:
                                              22895410]
                                         32. Svilar D, Dyavaiah M, Brown AR, Tang JB, Li J, McDonald PR, Shun TY, Braganza  Wang
                                              XH, Maniar S, St Croix CM, Lazo JS, Pollack  Begley TJ, Sobol RW. Mol Cancer Res. 2012
                                              [Epub ahead print.
                                         33. Baird EE, Dervan PB. Solid phase synthesis polyamides containing imidazole pyrrole
                                              amino acids. J Chem Soc. 1996; 118:6141–6146.
                                         34. Wurtz NR, Turner JM, Baird EE, Dervan PB. Fmoc solid phase synthesis polyamides containing
                                              pyrrole imidazole amino acids. Org Lett. 2001; 3:1201–1203. [PubMed: 11348194]
                                         35. Garbett NC, Ragazzon PA, Chaires JB. Circular dichroism determine binding mode affinity
NIH-PA Author Manuscript




                                              ligand-DNA interactions. Nat Protoc. 2007; 2:3166–3172. [PubMed: 18079716]
                                         36. Sidorova JM, Li N, Schwartz DC, Folch  Monnat RJ Jr. Microfluidic-assisted analysis                                               replicating DNA molecules. Nat Protoc. 2009; 4:849–861. [PubMed: 19444242]
                                         37. Kubo K, Ide H, Wallace SS, Kow YW. novel, sensitive, specific assay abasic sites,                                               commonly produced DNA lesion. Biochemistry. 1992; 31:3703–3708. [PubMed: 1567824]
                                         38. Kow YW, Dare  Detection abasic sites oxidative DNA base damage using ELISA-like
                                              assay. Methods. 2000; 22:164–169. [PubMed: 11020331]
                                         39. Nakamura J, Walker VE, Upton PB, Chiang SY, Kow YW, Swenberg JA. Highly sensitive
                                              apurinic/apyrimidinic site assay detect spontaneous chemically induced depurination
                                              physiological conditions. Cancer Res. 1998; 58:222–225. [PubMed: 9443396]
                                         40. Bennett SE, Kitner J. Characterization aldehyde reactive probe reaction AP-sites                                               DNA: influence AP-lyase adduct stability. Nucleosides Nucleotides Nucleic Acids. 2006;
                                              25:823–842. [PubMed: 16898421]



                                           Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                                 Page 17


                                         41. Dantzer F, Schreiber V, Niedergang C, Trucco C, Flatter E, La Rubia G, Oliver J, Rolli V,
                                             Ménissier Murcia J, Murcia G. Involvement poly(ADP-ribose) polymerase base
                                             excision repair. Biochimie. 1999; 81:69–75. [PubMed: 10214912]
NIH-PA Author Manuscript




                                         42. Khodyreva SN, Prasad R, Ilina ES, Sukhanova MV, Kutuzov MM, Liu Y, Hou EW, Wilson SH,
                                             Lavrik OI. Apurinic/apyrimidinic (AP) site recognition 5′-dRP/AP lyase poly(ADP-
                                             ribose) polymerase-1 (PARP-1). Proc Natl Acad Sci USA. 2010; 107:22090–22095. [PubMed:
                                             21127267]
                                         43. Eustermann S, Videler H, Yang JC, Cole PT, Gruszka D, Veprintsev D, Neuhaus D. DNA-
                                             binding domain human PARP-1 interacts DNA single-strand breaks monomer                                              second zinc finger. J Mol Biol. 2011; 407:149–170. [PubMed: 21262234]
                                         44. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage poly(ADP-
                                             ribose) polymerase proteinase properties like ICE. Nature. 1994; 371:346–347.
                                             [PubMed: 8090205]
                                         45. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997; 22:299–
                                             306. [PubMed: 9270303]
                                         46. Germain M, Affar EB, D’Amours D, Dixit VM, Salvesen GS, Poirier GG. Cleavage                                              automodified poly(ADP-ribose) polymerase apoptosis. Evidence involvement                                              caspase-7. J Biol Chem. 199; 274:28379–28384. [PubMed: 10497198]
                                         47. Beranek DT, Weis CC, Swenson DH. comprehensive quantitative analysis methylated                                              ethylated DNA using high pressure liquid chromatography. Carcinogenesis. 1980; 1:595–606.
                                             [PubMed: 11219835]
NIH-PA Author Manuscript




                                         48. Rinne ML, Y, Pachkowski BF, Nakamura J, Kelley MR. N-methylpurine DNA glycosylase
                                             overexpression increases alkylation sensitivity rapidly removing non-toxic 7-methylguanine
                                             adducts. Nucleic Acids Res. 2005; 33:2859–2867. [PubMed: 15905475]
                                         49. Goellner EM, Grimme B, Brown AR, Lin YC, Wang XH, Sugrue KF, Mitchell L, Trivedi RN,
                                             Tang JB, Sobol RW. Overcoming temozolomide resistance glioblastoma dual inhibition                                              NAD+ biosynthesis base excision repair. Cancer Res. 2011; 71:2308–2317. [PubMed:
                                             21406402]
                                         50. Calléja F, Jansen JG, Vrieling H, Laval F, van Zeeland AA. Modulation toxic mutagenic
                                             effects induced methyl methanesulfonate Chinese hamster ovary cells overexpression                                              rat N-alkylpurine DNA-glycosylase. Mutat Res. 1999; 425:185–194. [PubMed: 10216211]
                                         51. Chen DS, Herman T, Demple B. distinct human DNA diesterases hydrolyze 3′-blocking
                                             deoxyribose fragments oxidized DNA. Nucleic Acids Res. 1991; 19:5907–5914. [PubMed:
                                             1719484]
                                         52. Srivastava DK, Vande Berg BJ, Prasad R, Molina JT, Beard WA, Tomkinson AE, Wilson SH.
                                             Mammalian abasic site base excision repair. Identification reaction sequence rate-
                                             determining steps. J Biol Chem. 1998; 273:21203–21209. [PubMed: 9694877]
                                         53. Bobola MS, Varadarajan S, Smith NW, Goff RD, Kolstoe DD, Blank  Gold B, Silber JR. Human
                                             glioma cell sensitivity sequence-specific alkylating agent methyl-lexitropsin. Clin Cancer
                                             Res. 2007; 13:612–620. [PubMed: 17255284]
NIH-PA Author Manuscript




                                         54. Srinivasan  Wang L, Cline CJ, Xie  Sobol RW, Xie X-Q, Gold B. identification                                              characterization human AP endonuclease-1 inhibitors. Biochemistry. 2012; 51:6246–6259.
                                             [PubMed: 22788932]




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                              Page 18
NIH-PA Author Manuscript




                                         Figure 1.
                                         Structures compounds.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                        Page 19
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Figure 2.
                                           Formation N3-methyladenine (3-mA) 24 h incubation calf thymus DNA
                                         (100 μM nucleotide) compounds 1–4, 7 8 room temperature 10 mM sodium
                                         cacodylate buffer (pH 7.0): 1 (■), 2 (?), 3 (▲), 4 (▼), 7 (◆), 8. (✖) Formation 3-mA                                          N7-methylguanine (7-mG) incubation 1 7 calf thymus DNA 10 mM
NIH-PA Author Manuscript




                                         cacodylate buffer (pH 7.0) room temperature 24 h.




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                        Page 20
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Figure 3.
                                         Titration curve ICD spectrum sulfone derivatives minor groove binders 10 
NIH-PA Author Manuscript




                                         EtOH phosphate buffer (pH 7) 20 °C. CD 10 μM minor groove binder                                          presence increasing concentration (1 nM 0.1 mM, base pairs) CT DNA poly-
                                         d T): inset corresponding ICD spectra (arrow indicates increasing concentration                                          DNA):   netropsin + CT-DNA; (B) distamycin + CT-DNA; (C) netropsin + poly-d T);
                                         (D) distamycin + poly-d T); (E) 10 + CT-DNA; (F) 11 + CT-DNA; (G) 10 + poly-d 
                                         T); (H) 11 + poly-d T). Binding constants (Table 2) calculated using non-linear fit option
                                         Origin software.




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                           Page 21
NIH-PA Author Manuscript




                                         Figure 4.
                                         Toxicity 1–4, 7 8 wild type AB1157 E. coli (closed/bolded symbols) GC4803
                                         alkA/tag glycosylase mutant cells (open symbols/non-bolded): dipeptides 1 (■,□), 2 (?,○),
NIH-PA Author Manuscript




                                         3 (▲,△), 4 (▼, ▽) tripeptides 7 (◆,◇), 8 (✖, ✕) 9 (✚,+). Mid-log phase cells                                          exposed varying concentrations analogues 1 h, serially diluted survival
                                         measured solid LB media.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                       Page 22
NIH-PA Author Manuscript




                                         Figure 5.
                                         Toxicity WT T98G cells exposed varying concentrations dipeptide 1 (?) NIH-PA Author Manuscript




                                         tripeptide 7 (■) cell survival measured standard MTS assay. Data                                          fit using non-linear (curve-fit) Prism software.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                       Page 23
NIH-PA Author Manuscript




                                         Figure 6.
                                         Toxicity 1 T98G glioma cells: wild type (WT,?) MPG expressing cells
                                         (MPG+,■) MPG knock cells (MPG-,▲). cells exposed increasing
NIH-PA Author Manuscript




                                         concentrations 1 survival determined CyQuant assay 9 days exposure,                                          described Methods section.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                         Page 24
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Figure 7.
                                         Time-dependent effect di- tri-peptide methylating agents 1 7, respectively,                                          formation aldehyde reactive sites (ARS) WT, MPG expressing (MPG+) MPG
                                         deficient (MPG-) T98G cells:   WT DMSO (■), MPG+ DMSO (▲), MPG-
                                         DMSO (?),WT 80 μM 1 (□), MPG+ 80 μM 1 (△), MPG- 80 μM 1 (○);
NIH-PA Author Manuscript




                                         (B) WT DMSO (■), MPG+ DMSO (▲), MPG- DMSO (?),WT 7 μM 7
                                         (□), MPG+ 7 μM 7 (△), MPG- 7 μM 7 (○).




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                       Page 25
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Figure 8.
                                         Time course   PARP activation; (B) caspase-3 -7 activation; (C) cleavage                                          PARP T98G WT cells: (◇) untreated; (◆) 0.2  DMSO; (△) 80 μM 1; (▲) 250 μM 1.




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                  Page 26
NIH-PA Author Manuscript




                                         Figure 9.
                                         Normalized PAR production T98G glioma cells: wild type (WT, solid) MPG 
                                         expressing cells (MPG+, open columns) MPG knockdown cells (MPG-, hatched) NIH-PA Author Manuscript




                                         function concentration 1.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                       Page 27
NIH-PA Author Manuscript




                                         Figure 10.
                                         Microfluidic-assisted replication tract analysis (ma-RTA) A172 glioma cells                                          40 min exposure 5 10 μM 1:   experimental design; (B) images micro track
                                         capillaries; (C) percentile analysis track length (μm) B. Kolmogorov–Smirnov
NIH-PA Author Manuscript




                                         (K–S) test performed determine P-values different cumulative distributions.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                              Page 28
NIH-PA Author Manuscript




                                         Figure 11.
NIH-PA Author Manuscript




                                         Repair N3-methyladenine (3-mA) base excision repair.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                            Iyer et al.                                                                                 Page 29
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Scheme 1.
                                         Reagents conditions:   n-PrNH2, EtOAc; (ii) 10  Pd/C, EtOH; (iii) compound c,
                                         EDC, HOBT, Et3N, CH2Cl2; (iv) TFA, CH2Cl2; (v) 10  Pd/C, MeOH; (vi) CH2=CHCOCl,
                                         DIEA, THF; (vii) 1M TiCl4, CH2Cl2; (viii) compound f, EDC, HOBT, Et3N; (ix) NaHSO3,
                                         EtOH/H2O; (x) dioxane, 80 °C.
NIH-PA Author Manuscript




                                          Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                                                                           NIH-PA Author Manuscript                                             NIH-PA Author Manuscript                                        NIH-PA Author Manuscript


                                                                                                                                                                     Table 1

                                                                          Minor (3-mA) major (7-mG) groove adduct production (pmol/μg DNA) reaction 1 7 CT-DNA 
                                                                              compound concentration     1          7     1          7     1           7     1            7
                                                                                                                                                                                                                                                                         Iyer et al.




                                                                                                             1 μM             5 μM             10 μM             100 μM

                                                                                      3-mA             7.15    13.11    24.36    38.04   25.55    62.08    232.14    365.27

                                                                                      7-mA             0.04     0.13    0.13     0.22     0.43     0.39     3.56      3.13

                                                                                   3-mA/7-mG            179     101      187     173       59      159       65       117

                                                                                                                                                     Reactions conditions: 24 h incubation compounds CT-DNA (100 μM, p) room temperature 10 mM sodium phosphate buffer (pH 7.0). Data based HPLC analysis UV detection.




Chem Res Toxicol. Author manuscript; available PMC 2014 February 05.
                                                                                                                                                                                                                                                                         Page 30
                            Iyer et al.                                                                                                                             Page 31




                                                                                                     Table 2
                           Thermodynamic parameters equilibrium binding minor groove binding methylsulfones calf
NIH-PA Author Manuscript




                           thymus (CT)-DNA poly-d T 
                                                         ΔTM (°C)c                    Kb (M−1)d

                               Compoundb        CT-DNA        poly-d T)   CT-DNA        poly-d T)

                                     5             0.4            1.2         n.d.e           n.d.

                                     6             0.4            1.2         n.d.            n.d

                                    10             1.1            4.1       2.9 × 104       2.0 × 104

                                    11             1.1            4.7    